Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Strata Critical Medical (SRTA) Retained Earnings (2019 - 2025)

Strata Critical Medical (SRTA) has disclosed Retained Earnings for 7 consecutive years, with -$136.7 million as the latest value for Q3 2025.

  • Quarterly Retained Earnings fell 3376.25% to -$136.7 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was -$136.7 million through Sep 2025, down 3376.25% year-over-year, with the annual reading at $1.8 million for FY2024, 101.1% up from the prior year.
  • Retained Earnings for Q3 2025 was -$136.7 million at Strata Critical Medical, up from -$194.1 million in the prior quarter.
  • The five-year high for Retained Earnings was $4.2 million in Q3 2024, with the low at -$194.1 million in Q2 2025.
  • Average Retained Earnings over 5 years is -$75.6 million, with a median of -$77.2 million recorded in 2021.
  • The sharpest move saw Retained Earnings crashed 11445.43% in 2022, then skyrocketed 268.96% in 2023.
  • Over 5 years, Retained Earnings stood at -$898000.0 in 2021, then plummeted by 11445.43% to -$103.7 million in 2022, then tumbled by 54.09% to -$159.8 million in 2023, then skyrocketed by 101.1% to $1.8 million in 2024, then crashed by 7899.09% to -$136.7 million in 2025.
  • According to Business Quant data, Retained Earnings over the past three periods came in at -$136.7 million, -$194.1 million, and -$190.4 million for Q3 2025, Q2 2025, and Q1 2025 respectively.